Go to the content. | Move to the navigation | Go to the site search | Go to the menu | Contacts | Accessibility

| Create Account

Zarpellon, Alessandro (2008) Platelet interactions with a-thrombin and serotonin. [Ph.D. thesis]

Full text disponibile come:

Documento PDF

Abstract (english)

The aim of the first part of this thesis was to study platelets from people with essential thrombocytosis. Platelets from ET patients present several abnormalities. We focused on the abnormalities related with serotonin, in particular we wanted :
1) to determine the sub-cellular distribution of the neurotransmitter
2) to evaluate 5-HT transport in platelets either untreated or pre-incubated with reserpine, a known inhibitor of serotonin transport inside the dense granules
3) to establish whether the decreased accumulation of serotonin in pathological platelets was due to a decreased number of dense granules
4) to investigate the efficiency of the dense granules to accumulate basic amines;
5) to determine the amounts of ATP and Ca2+ contained in the dense granules
6) to evaluate the role of tyrosine kinases in the tranport of serotonin in platelets of MPDs subjects.
7) to analyze the serotonin-induced platelet activation (cytosolic [Ca2+] increase).
The second part of this thesis performed at the Scripps Research Institute (La Jolla, CA) in the laboratory directed by prof. Z.M. Ruggeri was to precisely define the functional role of tyrosine sulfation in the a-thrombin binding to GpIba, a receptor present in platelets, that play a pivotal role in haemostasis and thrombosis.

Statistiche Download - Aggiungi a RefWorks
EPrint type:Ph.D. thesis
Tutor:Deana, Renzo
Supervisor:Ruggeri, Zaverio
Ph.D. course:Ciclo 20 > Scuole per il 20simo ciclo > BIOCHIMICA E BIOTECNOLOGIE > BIOCHIMICA E BIOFISICA
Data di deposito della tesi:2008
Anno di Pubblicazione:2008
Key Words:Platelets, serotonin, a-thrombin, SERT, VMAT, GpIba, sulfation
Settori scientifico-disciplinari MIUR:Area 05 - Scienze biologiche > BIO/10 Biochimica
Struttura di riferimento:Dipartimenti > pre 2012 Dipartimento di Chimica Biologica
Codice ID:431
Depositato il:19 Sep 2008
Simple Metadata
Full Metadata
EndNote Format


I riferimenti della bibliografia possono essere cercati con Cerca la citazione di AIRE, copiando il titolo dell'articolo (o del libro) e la rivista (se presente) nei campi appositi di "Cerca la Citazione di AIRE".
Le url contenute in alcuni riferimenti sono raggiungibili cliccando sul link alla fine della citazione (Vai!) e tramite Google (Ricerca con Google). Il risultato dipende dalla formattazione della citazione.

1. Abrams CS. Intracellular signaling in platelets. Curr Opin Hematol. 2005; 12:401-5. Cerca con Google

2. Adams TE, Huntington JA. Thrombin-cofactor interactions: structural insights into regulatory mechanisms. Arterioscler Thromb Vasc Biol 2006; 26: 1738–45. Cerca con Google

3. Apparsundaram S,Galli A,DeFelice LJ,Hartzell HC,Blakely RD.Acute regulation of norepinephrine transport. I. PKC-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J Pharmacol Exp Ther. 1998;287:733-743. Cerca con Google

4. Apparsundaram S,Schroeter S,Blakely RD.Acute regulation of norepinephrine transport. II. PKC-modulated surface expression of human norepinephrine transporter proteins.J Pharmacol Exp Ther.1998;287:744-751. Cerca con Google

5. Aughan RA, Huff RA,Uhl GR,Kuhar MJ.Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes.J Biol Chem.1997;272:15541-15546. Cerca con Google

6. Adair BD, Xiong JP, Maddock C, Goodman SL, Arnaout MA, Yeager M. Threedimensional EM structure of the ectodomain of integrin {alpha}V{beta}3 in a complex with fibronectin. J Cell Biol 2005;168:1109–1118. Cerca con Google

7. Ahmad SS, Rawala-Sheikh R, Walsh PN. Comparative interactions of factor IX and factor IXa with human platelets. J Biol Chem 1989; 264:3244–51. Cerca con Google

8. Andrews RK, Shen Y, Gardiner EE, Dong JF, López JA, Berndt MC. The glycoprotein Ib-IX-V complex in platelet adhesion and signaling. Thromb Haemost 1999; 82: 357– 64. Cerca con Google

9. Andrews R.K., A.D. Munday, C.A. Mitchell and M.C. Berndt. Blood 98 (2001), pp. 681–687 Cerca con Google

10. Andrews and J.E. Fox. J. Biol. Chem. 267 (1992), pp. 18605–18611 Cerca con Google

11. Ayala YM, Cantwell AM, Rose T, Bush LA, Arosio D, Di Cera E. Molecular mapping of thrombin-receptor interactions. Proteins 2001;45: 107–16. Cerca con Google

12. Ayala Y, Di Cera E. Molecular recognition by thrombin. Role of the slow ? fast transition, site-specific ion binding energetics and thermodynamic mapping of structural components. J Mol Biol 1994; 235: 733-746 Cerca con Google

13. Arias-Salgado EG, et al. PTP-1B is an essential positive regulator of platelet integrin signaling. J Cell Biol 2005;170:837–845. Cerca con Google

14. Authi KS, Watson SP and Kakkar VV. Mechanisms of platelet activation and control. Plenum Press, New York, 1993. Cerca con Google

15. Babich M, King KL and Nissenson RA (1990) Thrombin stimulates inositol phosphate production and intracellular free calcium by a pertussis toxin-insensitive mechanism in osteosarcoma cells. Endocrinology 126: 948-954 Cerca con Google

16. Baffy G, Yang L, Raj S, Manning DR and Williamson JR (1994) G protein coupling to the thrombin receptor in Chinese hamster lung fibroblasts. J Biol Chem 269: 8483-8487 Cerca con Google

17. Bellucci S, Michiels JJ. Spontaneous proliferative megakaryopoiesis and platelet hyperactivity in essential thrombocythemia: is thrombopoietine the link?. Ann Hematol 2000; 79: 51-58 Cerca con Google

18. Berlin NI: Diagnosis and classification of the polycythemias. Semin Hematol 1975; 12: 339–351. Cerca con Google

19. Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979;64:1393–1401. Cerca con Google

20. Beuming, T., Shi, L., Javitch, J.A., Weinstein, H. 2006. A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function. Mol. Pharmacol. 70:1630–1642 Cerca con Google

21. Bernatowicz MS, Klimas CE, Hartl KS, Peluso M, Allegretto NJ, Seiler SM. Development of potent thrombin receptor antagonist peptides. J Med Chem 1996; 39: 4879– 87. Cerca con Google

22. Bergmeier W, et al. The role of platelet adhesion receptor GPIb{alpha} far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Natl Acad Sci USA 2006;103:16900–16905. Cerca con Google

23. Benka ML, Lee M, Wang GR, Buckman S, Burlacu A, Cole L, DePina A, Dias P, Granger A, Grant B, Haywardlester A, Karki S, Mann S, Marcu O, Nussenzweig A, Piepenhagen P, Raje M, Roegiers F, Rybak S, Salic A, Smithhall J, Waters J, Yamamoto N, Yanowitz J, Yeow K, Busa WB and Mendelsohn ME (1995) The thrombin receptor in human platelets is coupled to a GTP binding protein of the G alpha q family. FEBS Lett 363: 49- 52 Cerca con Google

24. Bhatt DL, Topol EJ. Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov 2003;2:15–28. Cerca con Google

25. Bode W, Mayr I, Baumann U. The refined 1.9 A crystal structure of human alphathrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J 1989; 8: 3467-3475 Cerca con Google

26. Brass LF, Manning DR, Cichowski K, Abrams CS. Signaling through G proteins in platelets: to the integrins and beyond. Thromb Haemost 1997;78:581–589. Cerca con Google

27. Brunk I, Höltje M, von Jagow B, Winter S, Sternberg J, Blex C, Pahner I, Ahnert-Hilger G. Regulation of vesicular monoamine and glutamate transporters by vesicle-associated trimeric G proteins: new jobs for long-known signal transduction molecules. Handb Exp Pharmacol. 2006;(175):305-25. Cerca con Google

28. D.C. Calverley, T.J. Kavanagh and G.J. Roth. Blood 91 (1998), pp. 1295–1303. Cerca con Google

29. Carter WJ, Cama E, Huntington JA. Crystal structure of thrombin bound to heparin. J Biol Chem 2005; 280: 2745–9. Cerca con Google

30. Chang CP, Zhao J, Wiedmer T, Sims PJ. Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J Biol Chem 1993;268:7171–7178. Cerca con Google

31. Coller BS. Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy. Circulation 1995;92:2373–2380. Cerca con Google

32. ChamberlainLH,GouldGW.The vesicle- and target-SNARE proteins that mediate Glut4 vesicle fusion are localized in detergent-insoluble lipid rafts present on distinct intracellular membranes. J Biol Chem. 2002; 277: 49750-49754. Cerca con Google

33. Chen J.G., Liu-Chen S., Rudnick G. 1998. Determination of external loop topology in the serotonin transporter by site-d Androutsellis-Theotokis A., Rudnick G. 2002. Accessibility and conformational coupling in serotonin transporter predicted internal domains. J. Neurosci. 22:8370–8378 Cerca con Google

34. N. Christodoulides, S. Feng, J.C. Resendiz, M.C. Berndt and M.H. Kroll. Thromb. Res. 102 (2001), pp. 133–142 Cerca con Google

35. Connolly AJ, Ishihara H, Kahn ML, Farese RV Jr, Coughlin SR. Role of the thrombin receptor in development and evidence for a second receptor. Nature 1996; 381: 516– 9. Cerca con Google

36. Covic L, Gresser AL. Kuliopulos A. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets. Biochemistry 2000; 39: 5458– 67. Cerca con Google

37. Cesar JM, de Miguel D, Garcia Avello A, Burgaleta C. Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100. Am J Clin Pathol 2005; 123: 772-777 Cerca con Google

38. Caranobe C, Sie P, Fernandez F, Pris J, Moatti S, Boneu B. (1984) Abnormal platelet serotonin uptake and binding sites in myeloproliferative disorders. Thromb Haemost 51; 349-53. Cerca con Google

39. Cortellazzo S, Viero P, Buczko W, Barbui T, De Gaetano G. (1985) Platelet 5- hydroxytryptamine transport and storage in myeloproliferative disorders. Scand J Haematol 34; 146-151. Cerca con Google

40. Casadevall N, Vainchenker W: A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144–1148. Cerca con Google

41. Cools J, Peeters P, Voet T, Aventin A, Mecucci C, Grandchamp B, Marynen P: Genomic organization of human JAK2 and mutation analysis of its JH2-domain in leukemia. Cytogenet Cell Genet 1999; 85: 260–266. Cerca con Google

42. Dahlback B, Stenflo J. Binding of bovine coagulation factor Xa to platelets. Biochemistry 1978; 17: 4938–45. Cerca con Google

43. Dameshek W: Some speculations on the myeloproliferative syndromes. Blood 1951; 6: 372–375. Cerca con Google

44. Dameshek W: Physiopathology and course of polycythemia vera as related to therapy. J Am Med Assoc 1950; 142: 790–797. Cerca con Google

45. De Candia E, Hall SW, Rutella S, Landolfi R, Andrews RK, De Cristofaro R. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets. J Biol Chem 2001; 276: 4692– 8. Cerca con Google

46. De Cristofaro R, De Candia E, Landolfi R, Rutella S, Hall SW. Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib. Biochemistry 2001; 40: 13268–73. Cerca con Google

47. De Gaetano G. Historical overview of the role of platelets in hemostasis and thrombosis. Haematologica 2001; 86:349-56. Cerca con Google

48. De Marco L, Mazzucato M, Fabris F, De Roia D, Coser P, Girolami A, Vicente V, Ruggeri ZM. Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex. J Clin Invest 1990; 86: 25– 31. Cerca con Google

49. De Marco L, Mazzucato M, Masotti A, Fenton JWd, Ruggeri ZM. Function of glycoprotein Ib alpha in platelet activation induced by alpha-thrombin. J Biol Chem 1991; 266: 23776– 83. Cerca con Google

50. De Marco L, Mazzucato M, Masotti A, Ruggeri ZM. Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha. J Biol Chem 1994; 269: 6478– 84. Cerca con Google

51. De Virgilio M, Kiosses WB, Shattil SJ. Proximal. selective, and dynamic interactions between integrin alphaIIbbeta3 and protein tyrosine kinases in living cells. J Cell Biol 2004;165:305–311. Cerca con Google

52. J.F. Dong, G. Sae-Tung and J.A. Lopez. Blood 89 (1997), pp. 4355–4363 Cerca con Google

53. C.Q. Li, J.F. Dong, F. Lanza, D.A. Sanan, G. Sae-Tung and J.A. Lopez. J. Biol. Chem. 270 (1995), pp. 16302–16307 Cerca con Google

54. Dumas JJ, Kumar R, Seehra J, Somers WS, Mosyak L. Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation. Science 2003; 301: 222–6. Cerca con Google

55. J.F. Dong, C.Q. Li and J.A. Lopez. Biochemistry 33 (1994), pp. 13946–13953 Cerca con Google

56. Du XP, Plow EF, Frelinger AL III, O’Toole TE, Loftus JC, Ginsberg MH. Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa). Cell 1991;65:409–416. Cerca con Google

57. X. Du, J.E. Fox and S. Pei.J. Biol. Chem. 271 (1996), pp. 7362–7367. Cerca con Google

58. G.D. Englund, R.J. Bodnar, Z. Li, Z.M. Ruggeri and X. Du. J. Biol. Chem. 276 (2001), pp. 16952–16959. Cerca con Google

59. Erickson, J.-D., Eiden, L.-E., and Hoffman, B.-J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 10993-10997 Cerca con Google

60. Faull RJ, Du X, Ginsberg MH. Receptors on platelets. Methods Enzymol 1994;245:183– 194. Cerca con Google

61. Flaumenhaft R. Molecular basis of platelet granule secretion. Arterioscler Thromb Vasc Biol 2003; 23:1152-60. Cerca con Google

62. Fee JA, Monsey JD, Handler RJ, Leonis MA, Mullaney SR, Hope HM and Silbert DF (1994) A Chinese hamster fibroblast mutant defective in thrombin-induced signaling has a low level of phospholipase C-beta 1. J Biol Chem 269: 21699-21708 Cerca con Google

63. Finazzi G, Budde U, Michiels JJ. Bleeding time and platelet function in essential thrombocythemia and other myeloproliferative disorders. Leuk Lymphoma 1996; 22 (supl1): 71-78 Cerca con Google

64. Fabris F, Randi M, Casonato A, Scattolo N, Girolami A. (1982) Platelet serotonin and platelet aggregation in the differential diagnosis of thrombocythosis. Thromb. Haemost. 48; 343-8. Cerca con Google

65. Fabris F, Randi M, Sbrojavacca R, Casonato A, Girolami A: The possible value of platelet aggregation studies in patients with increased platelet count . Blut 1981;43:279-285 Cerca con Google

66. S. Feng, J.C. Resendiz, X. Lu and M.H. Kroll. Blood 102 (2003), pp. 2122–2129. Cerca con Google

67. Fredenburgh JC, Stafford AR, Weitz JI. Evidence for allosteric linkage between exosites 1 and 2 of thrombin. J Biol Chem 1997; 272: 25493-25499 Cerca con Google

68. Geiger J. Inhibitors of platelet signal transduction as anti-aggregatory drugs. Expert Opin Investig Drugs 2001;10:865–890. Cerca con Google

69. Goncalves I, Hughan SC, Schoenwaelder SM, Yap CL, Yuan Y, Jackson SP. Integrin alpha IIb beta 3-dependent calcium signals regulate platelet-fibrinogen interactions under flow. Involvement of phospholipase C gamma 2. J Biol Chem 2003;278:34812– 34822. Cerca con Google

70. Gachet C. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs. Pharmacol Ther 2005; 108:180-92. Cerca con Google

71. Ginsberg MH, Forsyth J, Lightsey A, Chediak J, Plow EF. Reduced surface expression and binding of fibronectin by thrombin-stimulated thrombasthenic platelets. J Clin Invest 1983;71:619–624. Cerca con Google

72. Greengard JS, Heeb MJ, Ersdal E, Walsh PN, Griffin JH. Binding of coagulation factor XI to washed human platelets. Biochemistry 1986; 25: 3884–90. Cerca con Google

73. Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J Virol 1999;73:3951–3959. Cerca con Google

74. Hamilton JR,Cornelissen I,Coughlin SR. Impaired hemostasis and protection against thrombosis in protease-activated receptor 4-deficient mice is due to lack of thrombin signaling in platelets. J Thromb Haemost 2004; 2: 1429– 35. Cerca con Google

75. Hung DT, Wong YH, Vu TK and Coughlin SR (1992) The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase. J Biol Chem 267: 20831-20834 Cerca con Google

76. Hung DT, Vu TK, Wheaton VI, Ishii K, Coughlin SR. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J Clin Invest 1992; 89: 1350– 3. Cerca con Google

77. Hogg PJ, Jackson CM, Labanowski JK, Bock PE. Binding of fibrin monomer and heparin to thrombin in a ternary complex alters the environment of the thrombin catalytic site, reduces affinity for hirudin, and inhibits cleavage of fibrinogen. J Biol Chem 1996; 271:26088–95. Cerca con Google

78. Huntington JA. Molecular recognition mechanisms of thrombin. J Thromb Haemost 2005; 3: 1861–72 Cerca con Google

79. Hawiger J, Kloczewiak M, Timmons S, Strong D, Doolittle RF. Interaction of fibrinogen with staphylococcal clumping factor and with platelets. Ann NY Acad Sci 1983;408:521– 535. Cerca con Google

80. Heuck G: Zwei Fälle von Leukämie mit eigentümlichem Blut resp. Knochenmarksbefund. Virchows Arch 1879; 78: 475. Cerca con Google

81. Henry L.K., Adkins E.M., Han Q., Blakely R.D. 2003. Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I. J. Biol. Chem. 278:37052–37063 Cerca con Google

82. Hantgan RR. Fibrin protofibril and fibrinogen binding to ADP-stimulated platelets: evidence for a common mechanism. Biochim Biophys Acta 1988;968:24–35. Cerca con Google

83. M.J. Hickey, S.A. Williams and G.J. Roth. Proc. Natl. Acad. Sci. U. S. A. 86 (1989), pp. 6773–6777. Cerca con Google

84. F. Lanza, M. Morales, C. de La Salle, J.P. Cazenave, K.J. Clemetson, T. Shimomura and D.R. Phillips. J. Biol. Chem. 268 (1993), pp. 20801–20807. Cerca con Google

85. Jackson SP, Yap CL, Anderson KE. Phosphoinositide 3-kinases and the regulation of platelet function. Biochem Soc Trans 2004;32:387–392. Cerca con Google

86. Jardetzky O. 1966. Simple allosteric model for membrane pumps. Nature 211:969–970 Cerca con Google

87. Jencks W.P. 1980. The utilization of binding energy in coupled vectorial processes. Adv. Enzymol. Relat Areas Mol. Biol. 51:75–106 Cerca con Google

88. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, Garcon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, Score J, Seear R, Chase AJ, Grand FH, White H, Zoi C, Loukopoulos D, Terpos E, Vervessou EC, Schultheis B, Emig M, Ernst T, Lengfelder E, Hehlmann R, Hochhaus A, Oscier D, Silver RT, Reiter A, Cross NC: Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005; 106: 2162–2168. Cerca con Google

89. Jaffe SS, Harris NL, Sterm A, Vardiman JW:WHO Classification of Tumours: Tumours of Haematopoiesis and Lymphoid Tissues. Lyon, IARC, 2001, pp 31–42. Cerca con Google

90. Jayanthi LD,Samuvel DJ,Ramamoorthy S.Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters: evidence for localization in lipid rafts and lipid raft mediated internalization.J Biol Chem.2004;279:19315-19326. Cerca con Google

91. Kanthou C, Kanse SM, Kakkar VV and Benzakour O (1996) Involvement of pertussis toxin-sensitive and -insensitive G proteins in alpha-thrombin signalling on cultured human vascular smooth muscle cells. Cell Signalling Cerca con Google

92. Kanner, B. I., and Schuldiner, S. (1987) CRC Crit. Rev. Biochem. 22, 1-38 Cerca con Google

93. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC: A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352: 1779–1790. Cerca con Google

94. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR. Proteaseactivated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999; 103: 879– 87. Cerca con Google

95. Kane WH, Lindhout MJ, Jackson CM, Majerus PW. Factor Va dependent binding of factor Xa to human platelets. J Biol Chem 1980; 255: 1170–4. Cerca con Google

96. Karakantza M, Giannakoulas NC, Zikos P. Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia vera. Int J Hematol 2004; 79: 253-259 Cerca con Google

97. Kane WH, Majerus PW. The interaction of human coagulation factor Va with platelets. J Biol Chem 1982; 257: 3963–9. Cerca con Google

98. Kauffenstein G, et al. The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin – a phosphoinositide 3-kinase-dependent mechanism. FEBS Lett 2001;505:281–290. Cerca con Google

99. Karczewski J, Knudsen KA, Smith L, Murphy A, Rothman VL, Tuszynski GP. The interaction of thrombospondin with platelet glycoprotein GPIIb-IIIa. J Biol Chem 1989;264:21322–21326 Cerca con Google

100. Kasirer-Friede A, Cozzi MR, Mazzucato M, De Marco L, Ruggeri ZM, Shattil SJ. Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors. Blood 2004;103:3403–3411. Cerca con Google

101. D. Kenny, P.A. Morateck and R.R. Montgomery. Blood 99 (2002), pp. 4428–4433. Cerca con Google

102. S.A. Korrel, K.J. Clemetson, H. Van Halbeek, J.P. Kamerling, J.J. Sixma and J.F. Vliegenthart. Eur. J. Biochem. 140 (1984), pp. 571–576. Cerca con Google

103. F. Lanza, M. Morales, C. de La Salle, J.P. Cazenave, K.J. Clemetson, T. Shimomura and D.R. Phillips. J. Biol. Chem. 268 (1993), pp. 20801–20807. Cerca con Google

104. Le Bonniec BF, Esmon CT. Glu-192-Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin. Proc Natl Acad Sci 1991; 88: 7371-7375 Cerca con Google

105. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995;332:1553–1559. Cerca con Google

106. Lopez J. J., A. Camello-Almaraz, J.A. Pariente, G.M. Salido and J.A. Rosado, Ca2+ accumulation into acidic organelles mediated by Ca2+- and vacuolar H+-ATPases in human platelets, Biochem. J. 390 (2005), pp. 243–252. Cerca con Google

107. J.A. Lopez, D.W. Chung, K. Fujikawa, F.S. Hagen, T. Papayannopoulou and G.J. Roth. Proc. Natl. Acad. Sci. U. S. A. 84 (1987), pp. 5615–5619. Cerca con Google

108. J.A. Lopez, D.W. Chung, K. Fujikawa, F.S. Hagen, E.W. Davie and G.J. Roth. Proc. Natl. Acad. Sci. U. S. A. 85 (1988), pp. 2135–2139. Cerca con Google

109. Luo H, Rose P, Barber D, Hanratty WP, Lee S, Roberts TM, D’Andrea AD, Dearolf CR: Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol Cell Biol 1997; 17:1562–1571. Cerca con Google

110. Landolfi R, Ciabattoni G, Patrinani P. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. Blood 1992; 80: 1965-1971 Cerca con Google

111. Lian L, Wang Y, Draznin J, Eslin D, Bennett JS, Poncz M, Wu D, Abrams CS. The relative role of PLCb and PI3K_ in platelet activation. Blood 2005 106:110-7. Cerca con Google

112. Lacout C, Pisani DF, Tulliez M, Moreau Gachelin F, Vainchenker W, Villeval JL: JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis. Blood 2006; 108: 1652–1660. Cerca con Google

113. Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, Boggon TJ, Wlodarska I, Clark JJ, Moore S, Adelsperger J, Koo S, Lee JC, Gabriel S, Mercher T, D’Andrea A, Frohling S, Dohner K, Marynen P, Vandenberghe P, Mesa RA, Tefferi A, Griffin JD, Eck MJ, Sellers WR, Meyerson M, Golub TR, Lee SJ, Gilliland DG: Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia and myeloid metaplasia with myelofibrosis. Cancer Cell 2005; 7: 387–397. Cerca con Google

114. Liu, Y., Peter, D., Roghani, A., Schuldiner, S., Prive, G. G., Eisenberg, D., Brecha, N., and Edwards, R. H. (1992) Cell 70, 539-551 Cerca con Google

115. Litvinov RI, Shuman H, Bennett JS, Weisel JW. Binding strength and activation state of single fibrinogen-integrin pairs on living cells. Proc Natl Acad Sci USA 2002;99:7426– 7431 Cerca con Google

116. Malkowski MG,Martin PD, Guzik JC, Edwards BF. The co-crystal structure of unliganded bovine alpha-thrombin and prethrombin-2: movement of the Tyr-Pro-Pro- Trp segment and active site residues upon ligand binding. Protein Sci 1997; 6: 1438–48. Cerca con Google

117. P. Marchese, M. Murata, M. Mazzucato, P. Pradella, L. De Marco, J. Ware and Z.M. Ruggeri. J. Biol. Chem. 270 (1995), pp. 9571–9578. Cerca con Google

118. McNicol A, Israels SJ. Platelet dense granules: structure, function and implications for haemostasis. Thromb Res 1999; 95:1-18. Cerca con Google

119. Mondoro TH, Wall CD, White MM, Jennings LK. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor. Blood 1996;88:3824–3830. Cerca con Google

120. Mendolicchio GL, Ruggeri ZM. New perspectives on von Willebrand factor functions in hemostasis and thrombosis. Semin Hematol 2005;42:5–14. Cerca con Google

121. Marguerie GA, Plow EF, Edgington TS. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979;254:5357–5363. Cerca con Google

122. Mitchell S.M., Lee E., Garcia M.L., Stephan M.M. 2004. Structure and function of extracellular loop 4 of the serotonin transporter as revealed by cysteine-scanning mutagenesis. J. Biol. Chem. 279:24089–24099 Cerca con Google

123. Michiels JJ, Abels J, Steketee J, van Vliet HHDM, Vuzevski VD. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. Ann Intern Med 1985; 102: 466-471 Cerca con Google

124. Michiels JJ, van Genderen PJJ, Lindemans J, van Vliet HHDM. Erythromelalgic, thrombotic and hemorrhagic thrombocythemia. Leuk Lymphoma 1996; 22(suppl 1): 47- 56 Cerca con Google

125. Merickel A, Rosandich P, Peter D, Edwards RH. Identification of residues involved in substrate recognition by a vesicular monoamine transporter. J Biol Chem. 1995;270:25798-25804. Cerca con Google

126. Miletich JP, Jackson CM, Majerus PW. Properties of the factor Xa binding site on human platelets. J Biol Chem 1978; 253: 6908–16 Cerca con Google

127. Myles T, Yun TH, Hall SW, Leung LL. An extensive interaction interface between thrombin and factor V is required for factor V activation. J Biol Chem 2001; 276: 25143–9. Cerca con Google

128. S. Moog, P. Mangin, N. Lenain, C. Strassel, C. Ravanat, S. Schuhler, M. Freund, M. Santer, M. Kahn, B. Nieswandt, C. Gachet, J.P. Cazenave and F. Lanza. Blood 98 (2001), pp. 1038–1046. Cerca con Google

129. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, Coughlin SR. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000; 404: 609– 13 Cerca con Google

130. Nelson P.J., Rudnick G. 1979. Coupling between platelet 5-hydroxytryptamine and potassium transport. J. Biol. Chem. 254:10084–10089 Cerca con Google

131. Nurden AT. Glanzmann thrombasthenia. Orphanet J Rare Dis 2006;1:10. Cerca con Google

132. Offermanns S, Toombs CF, Hu YH, Simon MI. Defective platelet activation in G alpha(q)-deficient mice. Nature 1997; 389: 183– 6. Cerca con Google

133. O’Brien JR: “Exausted”platelets continue to circulate. Lancet 1978;ii:1316-1317 Cerca con Google

134. Offermanns S, Laugwitz KL, Spicher K, Schultz G. G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets. Proc Natl Acad Sci U S A 1994; 91: 504– 8. Cerca con Google

135. Ogino Y, Tanaka K and Shimizu N (1996) Direct evidence for two distinct G proteins coupling with thrombin receptors in human neuroblastoma SH-EP cells. Eur J Pharmacol 316: 105-109 Cerca con Google

136. Okamura T, Hasitz M, Jamieson GA. Platelet glycocalicin: interaction with thrombin and role as thrombin receptor on the platelet surface. J Biol Chem 1978; 253: 3435– 43. Cerca con Google

137. Ozaki Y, Asazuma N, Suzuki-Inoue K, Berndt MC. Platelet GPIb-IX-V-dependent signaling. J Thromb Haemost 2005;3:1745–1751. Cerca con Google

138. Panizzi P, Friedrich R, Fuentes-Prior P, Kroh HK, Briggs J, Tans G, Bode W, Bock PE. Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions. J Biol Chem 2006; 281: 1169–78. Cerca con Google

139. Parton RG,Richards AA.Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms.Traffic.2003;4:724-738. Cerca con Google

140. Peter, D., Jimenez, J., Liu, Y., Kim, J., and Edwards, R. H. (1994) J. Biol. Chem. 269, 7231-7237 Cerca con Google

141. Pareti FI, Gugliotta L. Mannucci L, Guarini A, Mannucci PM. (1982) Biochemical and metabolic aspects of platelet dysfunctions in chronic myeloproliferative disorders. Thromb. Haemost. 47; 84-9. Cerca con Google

142. Priestle JP, Rahuel J, Rink H, Tones M, Grutter MG. Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms. Protein Sci 1993; 2: 1630–42. Cerca con Google

143. Ramakrishnan V, DeGuzman F, Bao M, Hall SW, Leung LL, Phillips DR. A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. Proc Natl Acad Sci U S A 2001; 98: 1823– 8. Cerca con Google

144. Rawala-Sheikh R, Ahmad SS, Ashby B, Walsh PN. Kinetics of coagulation factor X activation by platelet-bound factor IXa. Biochemistry 1990; 29: 2606–11. Cerca con Google

145. Rosado J.A. , J.J. Lopez, A.G. Harper, M.T. Harper, P.C. Redondo, J.A. Pariente, S.O. Sage and G.M. Salido, Two pathways for store-mediated calcium entry differentially dependent on the actin cytoskeleton in human platelets, J. Biol. Chem. 279 (2004), pp. 29231–29235. Cerca con Google

146. RamamoorthyS,BlakelyRD.Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants.Science.1999;285:763-766. Cerca con Google

147. Rudnick G. 2002. Mechanisms of Biogenic Amine Neurotransmitter Transporters. In: Reith MEA, editor. Neurotransmitter Transporters, Structure, Function, and Regulation. Humana Press, Totowa, New Jersey, pp. 25–52 Cerca con Google

148. Rao AK. Molecular and biochemical basis for the platelet dysfunction in myeloproliferative disorders. Semin Hematol 2004 ; 41: 6-9. Cerca con Google

149. RudnickG, Fishkes H, Nelson PJ, Shuldiner S. (1980) Evidence for two distinct serotonin transport systems in platelets. J Biol Chem 255; 3638-41. Cerca con Google

150. Rocca B, Ciabattoni G, Tartaglione R. Increased thromboxane biosynthesis in essential thrombocythemia. Thromb Haemost 1995; 74: 1225-1230 Cerca con Google

151. RamamoorthyS,GiovanettiE,QianY,BlakelyRD.Phosphorylation and regulation of antidepressant-sensitive serotonin transporters.J Biol Chem.1998;273:2458-2466. Cerca con Google

152. Rudnick G., Nelson P.J. 1978. Platelet 5-hydroxytryptamine transport - an electroneutral mechanism coupled to potassium. Biochemistry 17:4739–4742 Cerca con Google

153. Ruggeri ZM. Mechanisms initiating platelet thrombus formation. Thromb Haemost 1997;78:611–616. Cerca con Google

154. Ruggeri ZM, Bader R, de Marco L. Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets. Proc Natl Acad Sci USA 1982;79:6038–6041. Cerca con Google

155. Rendu F, Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets 2001; 12:261-73. Cerca con Google

156. Schoenwaelder SM, Yuan Y, Cooray P, Salem HH, Jackson SP. Calpain cleavage of focal adhesion proteins regulates the cytoskeletal attachment of integrin alphaIIbbeta3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin clots. J Biol Chem 1997;272:1694–1702. Cerca con Google

157. Sambrano GR, Huang W, Faruqi T, Mahrus S, Craik C, Coughlin SR. Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 2000; 275: 6819– 23. Cerca con Google

158. Sambrano GR, Weiss EJ, Zheng YW, Huang W, Coughlin SR. Role of thrombin signalling in platelets in haemostasis and thrombosis. [Comment In: Nature. 2001 Sep 6;413(6851):26–7 UI: 21429411]. Nature 2001; 413: 74– 8. Cerca con Google

159. Scandura JM, Ahmad SS, Walsh PN. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin. Biochemistry 1996; 35: 8890–902 Cerca con Google

160. Schechter I, Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 1967; 27: 157-162 Cerca con Google

161. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substratereceptor interactions in platelet thrombus formation under flow. Cell 1998;94:657–666. Cerca con Google

162. Scarborough RM, Kleiman NS, Phillips DR. Platelet glycoprotein IIb/III antagonists. What are the relevant issues concerning their pharmacology and clinical use? Circulation 1999;100:437–444. Cerca con Google

163. Shattil SJ, Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood 2004;104:1606–1615. Cerca con Google

164. SamuvelDJ,JayanthiLD,BhatNR,RamamoorthyS.A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression.J Neurosci.2005;25:29-41. Cerca con Google

165. Sato Y., Zhang Y.-W., Androutsellis-Theotokis A., Rudnick G. 2004. Analysis of transmembrane domain 2 of rat serotonin transporter by cysteine scanning mutagenesis. J. Biol. Chem. 279:22926–22933 Cerca con Google

166. Smith JW, Piotrowicz RS, Mathis D. A mechanism for divalent cation regulation of beta 3-integrins. J Biol Chem 1994;269:960–967. Cerca con Google

167. Selheim F, Froyset AK, Strand I, Vassbotn FS, Holmsen H. Adrenaline potentiates PI 3- kinase in platelets stimulated with thrombin and SFRLLN: role of secreted ADP. FEBS Lett 2000;485:62-6. Cerca con Google

168. Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem 1985;260:11107– 11114. Cerca con Google

169. Shapiro MJ, Weiss EJ, Faruqi TR, Coughlin SR. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J Biol Chem 2000; 275: 25216– 21. Cerca con Google

170. Y. Shen, J.F. Dong, G.M. Romo, W. Arceneaux, A. Aprico, E.E. Gardiner, J.A. Lopez, M.C. Berndt and R.K. Andrews. Blood 99 (2002), pp. 145–150 Cerca con Google

171. Siess W, Grunberg B, Luber K. Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition. Adv Exp Med Biol 1993;344:229–235. Cerca con Google

172. Sinha D, Seaman FS, Koshy A, Knight LC,Walsh PN. Blood coagulation factor Xia binds specifically to a site on activated human platelets distinct from that for factor XI. J Clin Invest 1984; 73: 1550–6. Cerca con Google

173. Selak MA, Chignard M, Smith JB. Cathepsin G is a strong platelet agonist released by neutrophils. Biochem J 1988; 251: 293– 9. Cerca con Google

174. Suzuki A, Kozawa O, Shinoda J, Watanabe Y, Saito H and Oiso Y (1996) Thrombin induces proliferation of osteoblast-like cells through phosphatidylcholine hydrolysis. J Cell Physiol 168: 209-216 Cerca con Google

175. Swift S, Sheridan PJ, Covic L and Kuliopulos A (2000) Par1 thrombin receptor-G protein interactions separation of binding and coupling determinants in the G alpha subunit. J Biol Chem 275: 2627-2635 Cerca con Google

176. Talvenheimo J., Fishkes H., Nelson P.J., Rudnick G. 1983. The serotonin transporterimipramine ’receptor’: Different sodium requirements for imipramine binding and serotonin translocation. J. Biol. Chem. 258:6115–6119 Cerca con Google

177. Rudnick G. 1998. Bioenergetics of neurotransmitter transport. J. Bioenerget. Biomembr. 30:173–185 Cerca con Google

178. Takagi J, Petre BM, Walz T, Springer TA. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 2002;110:599– 511. Cerca con Google

179. Tanford C. 1983. Translocation pathway in the catalysis of active transport. Proc. Natl. Acad. Sci. USA 80:3701–3705 Cerca con Google

180. Tate C., Blakely R. 1994. The effect of N-linked glycosylation on activity of the Na+-and Cl?-dependent serotonin transporter expressed using recombinant baculovirus in insect cells. J. Biol. Chem. 269:26303–26310 Cerca con Google

181. Thiagarajan P, Kelly KL. Exposure of binding sites for vitronectin on platelets following stimulation. J Biol Chem 1988;263:3035–3038. Cerca con Google

182. Thiele J, Kvasnicka HM, Diehl V: Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia. Acta Haematol 2005; 113: 213– 219. Cerca con Google

183. Tracy PB, Peterson JM, Nesheim ME, McDuffie FC, Mann KG. Interaction of coagulation factor Vand factor Va with platelets. J Biol Chem 1979; 254: 103541. Cerca con Google

184. Tsiang M, Jain AK, Dunn KE, Rojas ME, Leung LL, Gibbs CS. Functional mapping of the surface residues of human thrombin. J Biol Chem 1995; 270: 16854–63. Cerca con Google

185. Tomiyama Y, Kunicki TJ, Zipf TF, Ford SB, Aster RH. Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expression. Blood 1992;80:2261–2268. Cerca con Google

186. Turetta L, Bazzan E, Bertagno K, Musacchio E, Deana R. Role of Ca(2+) and protein kinase C in the serotonin (5-HT) transport in human platelets.Cell Calcium. 2002 May;31(5):235-44. Cerca con Google

187. Van Genderen PJJ, Prins F, Michiels JJ, Schrör K. Thromboxane-dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: a rationale for the use of low-dose aspirin as an antithrombotic agent. Br J Haematol 1999; 104: 438-441 Cerca con Google

188. Verhamme IM, Olson ST, Tollefsen DM, Bock PE. Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II. J Biol Chem 2002; 277: 6788–98 Cerca con Google

189. Vindigni A,Di Cera E. Release of fibrinopeptides by the slow and fast forms of thrombin. Biochemistry 1996; 35: 4417–26. Cerca con Google

190. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057– 68. Cerca con Google

191. Ware J, Russell SR, Vicente V, Scharf RE, Tomer A, McMillan R, Ruggeri ZM. Nonsense mutation in the glycoprotein Ib alpha coding sequence associated with Bernard-Soulier syndrome. Proc Natl Acad Sci U S A 1990; 87: 2026– 30. Cerca con Google

192. Watson SP, Auger JM, McCarty OJ, Pearce AC. GPVI and integrin alphaIIb beta3 signaling in platelets. J Thromb Haemost 2005;3:1752–1762. Cerca con Google

193. Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 1996;88:907–914. Cerca con Google

194. M.R. Wardell, C.C. Reynolds, M.C. Berndt, R.W. Wallace and J.E. Fox. J. Biol. Chem. 264 (1989), pp. 15656–15661 Cerca con Google

195. Weiss HJ, Turitto VT, Baumgartner HR. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood 1986;67:322–330. Cerca con Google

196. Wernig G, Mercher T, Okabe R, Levine RL, Lee BH, Gilliland DG: Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. Blood 2006; 107: 4274–4281. Cerca con Google

197. Wonerow P, Pearce AC, Vaux DJ, Watson SP. A critical role for phospholipase Cg Cerca con Google

198. Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW, Foster DC. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci U S A 1998; 95: 6642– 6. Cerca con Google

199. J.C. Whisstock, Y. Shen, J.A. Lopez, R.K. Andrews and M.C. Berndt. Thromb. Haemost. 87 (2002), pp. 329–333 Cerca con Google

200. Winitz S, Gupta SK, Qian NX, Heasley LE, Nemenoff RA and Johnson GL (1994) Expression of a mutant Gi2 alpha subunit inhibits ATP and thrombin stimulation of cytoplasmic phospholipase A2-mediated arachidonic acid release independent of Ca2+ and mitogen-activated protein kinase regulation. J Biol Chem 269: 1889-1895 Cerca con Google

201. Yelin R, Schuldiner S. Vesicular neurotransmitter transporters: pharmacology, biochemistry, and molecular analysis. In: Reith MEA, ed. Neurotransmitter Transporters; Structure, Function, and Regulation. 2nd ed. Totowa, NJ: Humana Press; 2002:313-354. Cerca con Google

202. Yun TH, Baglia FA, Myles T, Navaneetham D, Lopez JA, Walsh PN, et al. Thrombin activation of factor XI on activated platelets requires the interaction of factor XI and platelet glycoprotein Ib alpha with thrombin anion-binding exosites I and II, respectively. J Biol Chem 2003; 278: 48112–9. Cerca con Google

203. Zarpellon A, Donella-Deana A, Folda A, Turetta L, Pavanetto M, Deana R. Serotonin (5-HT) Transport in Human Platelets is Modulated by Src-Catalysed Tyr- Phosphorylation of the Plasma Membrane Transporter SERT. Cell Physiol Biochem 2008;21:87-94. Cerca con Google

Download statistics

Solo per lo Staff dell Archivio: Modifica questo record